M. Heinzelmann et al., Modulation of lipopolysaccharide-induced monocyte activation by heparin-binding protein and fucoidan, INFEC IMMUN, 66(12), 1998, pp. 5842-5847
Activated polymorphonuclear leukocytes release heparin-binding protein (HBP
; also known as CAP37 or azurocidin) from azurophilic granules. HBP is a st
rong chemoattractant for monocytes that also prolongs monocyte survival and
potentiates endotoxin (lipopolysaccharide [LPS])-induced production of tum
or necrosis factor alpha (TNF-alpha). We investigated the binding of fluore
scein isothiocyanate-conjugated HBP to human monocytes in the presence of E
DTA and the polysaccharide fucoidan. EDTA, which chelates divalent cations,
has been widely used to study the role of divalent cations in receptor-lig
and interactions or enzyme activity. Fucoidan has been used to inhibit the
binding of various ligands to scavenger receptors or selectins. Scavenger r
eceptors are multiligand receptors that mediate endocytosis of proteases, p
rotease-inhibitor complexes, lipoproteins, and LPS-lipid A. Fucoidan also i
nterferes with leukocyte rolling by binding to L-selectins (expressed on le
ukocytes) and P-selectins (expressed on platelets and endothelium). We demo
nstrate that the binding of the neutrophil-derived protein HBP to monocytes
is inhibited in the presence of EDTA and fucoidan. In addition, fucoidan a
nd EDTA abrogate the enhancing effect of HBP on LPS-induced TNF-alpha produ
ction. These data provide supporting evidence that HBP binds to a receptor
expressed on monocytes. This receptor is dependent on divalent cations and
is possibly related to the scavenger receptor. Furthermore, we demonstrate
that fucoidan, by itself, stimulates TNF-alpha release from isolated monocy
tes in a CD14-independent fashion. This is an important finding for the int
erpretation of results from studies that use fucoidan to "block" either sca
venger receptors or L- or P-selectins.